Combination Therapy of Ceftazidime/Avibactam for the Treatment of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Multicenter Retrospective Study.

Jing Lin,Li Zhang,Menglan Zhou,Xiaotong Tian,Jialong Chen,Minya Lu,Zhengyin Liu

Infectious diseases and therapy（2023）

引用 0|浏览7

暂无评分

摘要

Combination therapy (or CAZ/AVI combined with tigecycline) and monotherapy with CAZ/AVI had similar prognoses in patients with only CRKP infection (or CRKP-associated pneumonia), as well as in critically ill patients. Larger randomized controlled trials are warranted to confirm these findings.

查看译文

关键词

Ceftazidime/avibactam, Carbapenem-resistant Klebsiella pneumoniae, Tigecycline, Pneumonia, Combination therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要